Medical device company Ra Medical Systems Inc (NYSE:RMED) stated on Friday that recorded a net loss of USD17.4m (USD1.30 per share) for the three months ended 30 September 2019.
This marks a decline in earnings when compared with a lower net loss of USD4.8m (USD0.59 per share) for the third quarter of 2018.
Net revenue of USD1.9m was generated for the third quarter of 2019, down over net revenue of USD2.1m for the previous third quarter.
Adjusted EBITDA was negative USD9.9m for the third quarter of 2019, versus adjusted EBITDA of negative USD3.1m for the third quarter of 2018.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project